Bayer has filed for approval in the US for elinzanetant as a non-hormonal treatment for menopausal symptoms such as hot flushes, with a rival therapy from Astellas in its sights. The FDA submission is ...

Effective October 20, a new validation has been introduced. To prevent your submission from being rejected, please remove all optional fields without values from your XML file. When and how to file, ...